Abstract
Pulmonary hypertension (PH) is a haemodynamic and pathophysiological condition defined as an increase in mean pulmonary arterial pressure at rest ⩾ 25 mmHg as assessed by right heart catheterization. Haemodynamically PH can be further distinguished into pre-capillary PH depending on the presence of a raised left atrial or pulmonary wedge pressure. Post-capillary PH is common in patients with congenital heart disease, in whom systemic ventricular dysfunction, valve disease, outflow tract obstruction or pulmonary venous stenosis can lead to a rise in post-capillary pressures. In this chapter, we discuss the pathogenesis, impact and management of postcapillary PH in congenital heart disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ACHD:
-
adult congenital heart disease
- CHD:
-
congenital heart disease
- ccTGA:
-
congenitally corrected transposition of the great arteries
- Cpc-PH:
-
combined post-capillary and pre-capillary PH
- DPG:
-
diastolic pulmonary pressure gradient
- ECG:
-
electrocardiography
- HF:
-
heart failure
- HFrEF:
-
heart failure with reduced ejection fraction
- HFpEF:
-
heart failure with preserved ejection fraction
- Ipc-PH:
-
isolated post-capillary PH
- LA:
-
left atrium
- LHD:
-
left heart disease
- LV:
-
left ventricle
- LVAD:
-
left ventricle assist device
- LVEDP:
-
left ventricular end-diastolic pressure
- LVEF:
-
left ventricular ejection fraction
- mPAP:
-
mean pulmonary arterial pressure
- PAH:
-
pulmonary arterial hypertension
- PH:
-
pulmonary hypertension
- PAP:
-
pulmonary arterial pressure
- PAWP:
-
pulmonary artery wedge pressure
- PVR:
-
pulmonary vascular resistance
- RHC:
-
right heart catheterization
- SVR:
-
systemic vascular resistance
- TGA:
-
transposition of the great arteries
- TPG:
-
trans-pulmonary pressure gradient
- WHO:
-
World Health Organization
- WU:
-
Wood units
References
Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, Aboyans V, Vaz Carneiro A, Achenbach S, Agewall S, Allanore Y, Asteggiano R, Paolo Badano L, Albert Barbera J, Bouvaist H, Bueno H, Byrne RA, Carerj S, Castro G, Erol C, Falk V, Funck-Brentano C, Gorenflo M, Granton J, Iung B, Kiely DG, Kirchhof P, Kjellstrom B, Landmesser U, Lekakis J, Lionis C, Lip GY, Orfanos SE, Park MH, Piepoli MF, Ponikowski P, Revel MP, Rigau D, Rosenkranz S, Voller H, Luis Zamorano J (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37:67–119
Vachiery JL, Adir Y, Barbera JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galie N, Ghio S, Gibbs JS, Martinez F, Semigran M, Simonneau G, Wells A, Seeger W (2013) Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol 62:D100–D108
Naeije R, Vachiery JL, Yerly P, Vanderpool R (2013) The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease. Eur Respir J 41:217–223
Gerges C, Gerges M, Lang MB, Zhang Y, Jakowitsch J, Probst P, Maurer G, Lang IM (2013) Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in “out-of-proportion” pulmonary hypertension. Chest 143:758–766
Tampakakis E, Leary PJ, Selby VN, De Marco T, Cappola TP, Felker GM, Russell SD, Kasper EK, Tedford RJ (2015) The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. JACC Heart Fail 3:9–16
Tampakakis E, Tedford RJ (2015) Reply: characterization of pulmonary hypertension in heart failure using the diastolic pressure gradient: the conundrum of high and low diastolic pulmonary gradient. JACC Heart Fail 3:426–427
Thenappan T, Shah SJ, Gomberg-Maitland M, Collander B, Vallakati A, Shroff P, Rich S (2011) Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction. Circ Heart Fail 4:257–265
Robbins IM, Newman JH, Johnson RF, Hemnes AR, Fremont RD, Piana RN, Zhao DX, Byrne DW (2009) Association of the metabolic syndrome with pulmonary venous hypertension. Chest 136:31–36
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200
Miller WL, Grill DE, Borlaug BA (2013) Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure. JACC Heart Fail 1:290–299
Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R, Arbustini E, Recusani F, Tavazzi L (2001) Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 37:183–188
Kjaergaard J, Akkan D, Iversen KK, Kjoller E, Kober L, Torp-Pedersen C, Hassager C (2007) Prognostic importance of pulmonary hypertension in patients with heart failure. Am J Cardiol 99:1146–1150
Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachiery JL (2016) Left ventricular heart failure and pulmonary hypertensiondagger. Eur Heart J 37:942–954
Shapiro BP, McGoon MD, Redfield MM (2007) Unexplained pulmonary hypertension in elderly patients. Chest 131:94–100
Gerges M, Gerges C, Pistritto AM, Lang MB, Trip P, Jakowitsch J, Binder T, Lang IM (2015) Pulmonary hypertension in heart failure. Epidemiology, right ventricular function, and survival. Am J Respir Crit Care Med 192:1234–1246
Faggiano P, Antonini-Canterin F, Ribichini F, D’Aloia A, Ferrero V, Cervesato E, Pavan D, Burelli C, Nicolosi G (2000) Pulmonary artery hypertension in adult patients with symptomatic valvular aortic stenosis. Am J Cardiol 85:204–208
Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33:2451–2496
Melby SJ, Moon MR, Lindman BR, Bailey MS, Hill LL, Damiano RJ Jr (2011) Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg 141:1424–1430
Banerjee A, Kohl T, Silverman NH (1995) Echocardiographic evaluation of congenital mitral valve anomalies in children. Am J Cardiol 76:1284–1291
Goodale F Jr, Sanchez G, Friedlich AL, Scannell JG, Myers GS (1955) Correlation of pulmonary arteriolar resistance with pulmonary vascular changes in patients with mitral stenosis before and after valvulotomy. N Engl J Med 252:979–983
Shone JD, Sellers RD, Anderson RC, Adams P Jr, Lillehei CW, Edwards JE (1963) The developmental complex of “parachute mitral valve,” supravalvular ring of left atrium, subaortic stenosis, and coarctation of aorta. Am J Cardiol 11:714–725
Brauner RA, Laks H, Drinkwater DC Jr, Scholl F, McCaffery S (1997) Multiple left heart obstructions (shone’s anomaly) with mitral valve involvement: long-term surgical outcome. Ann Thorac Surg 64:721–729
Oudiz RJ (2007) Pulmonary hypertension associated with left-sided heart disease. Clin Chest Med 28:233–241, x
ten Freyhaus H, Dagnell M, Leuchs M, Vantler M, Berghausen EM, Caglayan E, Weissmann N, Dahal BK, Schermuly RT, Ostman A, Kappert K, Rosenkranz S (2011) Hypoxia enhances platelet-derived growth factor signaling in the pulmonary vasculature by down-regulation of protein tyrosine phosphatases. Am J Respir Crit Care Med 183:1092–1102
Delgado JF, Conde E, Sanchez V, Lopez-Rios F, Gomez-Sanchez MA, Escribano P, Sotelo T, Gomez de la Camara A, Cortina J, de la Calzada CS (2005) Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure. Eur J Heart Fail 7:1011–1016
Melenovsky V, Hwang SJ, Lin G, Redfield MM, Borlaug BA (2014) Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 35:3452–3462
Piran S, Veldtman G, Siu S, Webb GD, Liu PP (2002) Heart failure and ventricular dysfunction in patients with single or systemic right ventricles. Circulation 105:1189–1194
Khairy P, Landzberg MJ, Lambert J, O’Donnell CP (2004) Long-term outcomes after the atrial switch for surgical correction of transposition: a meta-analysis comparing the mustard and senning procedures. Cardiol Young 14:284–292
Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbely A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the european society of cardiology. Eur Heart J 28:2539–2550
Frost AE, Farber HW, Barst RJ, Miller DP, Elliott CG, McGoon MD (2013) Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm hg: insights from the reveal registry. Chest 143:185–195
Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, Strickland W, Neelagaru S, Raval N, Krueger S, Weiner S, Shavelle D, Jeffries B, Yadav JS (2011) Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 377:658–666
Prasad A, Hastings JL, Shibata S, Popovic ZB, Arbab-Zadeh A, Bhella PS, Okazaki K, Fu Q, Berk M, Palmer D, Greenberg NL, Garcia MJ, Thomas JD, Levine BD (2010) Characterization of static and dynamic left ventricular diastolic function in patients with heart failure with a preserved ejection fraction. Circ Heart Fail 3:617–626
Robbins IM, Hemnes AR, Pugh ME, Brittain EL, Zhao DX, Piana RN, Fong PP, Newman JH (2014) High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Circ Heart Fail 7:116–122
Fujimoto N, Borlaug BA, Lewis GD, Hastings JL, Shafer KM, Bhella PS, Carrick-Ranson G, Levine BD (2013) Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure. Circulation 127:55–62
Maeder MT, Thompson BR, Brunner-La Rocca HP, Kaye DM (2010) Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. J Am Coll Cardiol 56:855–863
Paulus WJ (2010) Culprit mechanism(s) for exercise intolerance in heart failure with normal ejection fraction. J Am Coll Cardiol 56:864–866
Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJ, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E (2010) Esc guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 31:2915–2957
Seale AN, Daubeney PE, Magee AG, Rigby ML (2006) Pulmonary vein stenosis: initial experience with cutting balloon angioplasty. Heart 92:815–820
Lewis GD, Lachmann J, Camuso J, Lepore JJ, Shin J, Martinovic ME, Systrom DM, Bloch KD, Semigran MJ (2007) Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation 115:59–66
Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, Tawakol A, Gerszten RE, Systrom DM, Bloch KD, Semigran MJ (2007) Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation 116:1555–1562
Etz CD, Welp HA, Tjan TD, Hoffmeier A, Weigang E, Scheld HH, Schmid C (2007) Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices. Ann Thorac Surg 83:1697–1705
Nair PK, Kormos RL, Teuteberg JJ, Mathier MA, Bermudez CA, Toyoda Y, Dew MA, Simon MA (2010) Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension. J Heart Lung Transplant 29:201–208
Pauwaa S, Bhat G, Tatooles AJ, Aggarwal A, Martin M, Kumar A, Modi H, Pappas PS (2012) How effective are continuous flow left ventricular assist devices in lowering high pulmonary artery pressures in heart transplant candidates? Cardiol J 19:153–158
Zimpfer D, Zrunek P, Sandner S, Schima H, Grimm M, Zuckermann A, Wolner E, Wieselthaler G (2007) Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices. Eur J Cardiothorac Surg 31:698–702
Breinholt JP, Hawkins JA, Minich LA, Tani LY, Orsmond GS, Ritter S, Shaddy RE (1999) Pulmonary vein stenosis with normal connection: associated cardiac abnormalities and variable outcome. Ann Thorac Surg 68:164–168
Hancock Friesen CL, Zurakowski D, Thiagarajan RR, Forbess JM, del Nido PJ, Mayer JE, Jonas RA (2005) Total anomalous pulmonary venous connection: an analysis of current management strategies in a single institution. Ann Thorac Surg 79:596–606; discussion 596–606
Caldarone CA, Najm HK, Kadletz M, Smallhorn JF, Freedom RM, Williams WG, Coles JG (1998) Relentless pulmonary vein stenosis after repair of total anomalous pulmonary venous drainage. Ann Thorac Surg 66:1514–1520
Latson LA, Prieto LR (2007) Congenital and acquired pulmonary vein stenosis. Circulation 115:103–108
Holt DB, Moller JH, Larson S, Johnson MC (2007) Primary pulmonary vein stenosis. Am J Cardiol 99:568–572
Yun TJ, Coles JG, Konstantinov IE, Al-Radi OO, Wald RM, Guerra V, de Oliveira NC, Van Arsdell GS, Williams WG, Smallhorn J, Caldarone CA (2005) Conventional and sutureless techniques for management of the pulmonary veins: evolution of indications from postrepair pulmonary vein stenosis to primary pulmonary vein anomalies. J Thorac Cardiovasc Surg 129:167–174
Devaney EJ, Chang AC, Ohye RG, Bove EL (2006) Management of congenital and acquired pulmonary vein stenosis. Ann Thorac Surg 81:992–995; discussion 995–996
Tomita H, Watanabe K, Yazaki S, Kimura K, Ono Y, Yagihara T, Echigo S (2003) Stent implantation and subsequent dilatation for pulmonary vein stenosis in pediatric patients: maximizing effectiveness. Circ J 67:187–190
Mendelsohn AM, Bove EL, Lupinetti FM, Crowley DC, Lloyd TR, Fedderly RT, Beekman RH 3rd (1993) Intraoperative and percutaneous stenting of congenital pulmonary artery and vein stenosis. Circulation 88:Ii210–Ii217
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Brida, M., Diller, GP. (2017). Post-capillary Pulmonary Hypertension in ACHD. In: Dimopoulos, K., Diller, GP. (eds) Pulmonary Hypertension in Adult Congenital Heart Disease. Congenital Heart Disease in Adolescents and Adults. Springer, Cham. https://doi.org/10.1007/978-3-319-46028-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-46028-4_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-46026-0
Online ISBN: 978-3-319-46028-4
eBook Packages: MedicineMedicine (R0)